193 related articles for article (PubMed ID: 26387984)
1. Wogonoside inhibits angiogenesis in breast cancer via suppressing Wnt/β-catenin pathway.
Huang Y; Zhao K; Hu Y; Zhou Y; Luo X; Li X; Wei L; Li Z; You Q; Guo Q; Lu N
Mol Carcinog; 2016 Nov; 55(11):1598-1612. PubMed ID: 26387984
[TBL] [Abstract][Full Text] [Related]
2. Wogonoside Inhibits Prostate Cancer Cell Growth and Metastasis via Regulating Wnt/β-Catenin Pathway and Epithelial-Mesenchymal Transition.
Wei C; Jing J; Zhang Y; Fang L
Pharmacology; 2019; 104(5-6):312-319. PubMed ID: 31480051
[TBL] [Abstract][Full Text] [Related]
3. Wogonin influences vascular permeability via Wnt/β-catenin pathway.
Song X; Zhou Y; Zhou M; Huang Y; Li Z; You Q; Lu N; Guo Q
Mol Carcinog; 2015 Jul; 54(7):501-12. PubMed ID: 24136474
[TBL] [Abstract][Full Text] [Related]
4. A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling.
Huang Y; Fang J; Lu W; Wang Z; Wang Q; Hou Y; Jiang X; Reizes O; Lathia J; Nussinov R; Eng C; Cheng F
Cell Chem Biol; 2019 Aug; 26(8):1143-1158.e6. PubMed ID: 31178408
[TBL] [Abstract][Full Text] [Related]
5. Wogonoside exerts growth-suppressive effects against T acute lymphoblastic leukemia through the STAT3 pathway.
Xiao R; Gan M; Jiang T
Hum Exp Toxicol; 2017 Nov; 36(11):1169-1176. PubMed ID: 27941168
[TBL] [Abstract][Full Text] [Related]
6. Wogonoside impedes the progression of acute myeloid leukemia through inhibiting bone marrow angiogenesis.
Lin B; Zhao K; Yang D; Bai D; Liao Y; Zhou Y; Yu Z; Yu X; Guo Q; Lu N
J Cell Physiol; 2019 Feb; 234(2):1913-1924. PubMed ID: 30105796
[TBL] [Abstract][Full Text] [Related]
7. Wogonoside inhibits lipopolysaccharide-induced angiogenesis in vitro and in vivo via toll-like receptor 4 signal transduction.
Chen Y; Lu N; Ling Y; Gao Y; Wang L; Sun Y; Qi Q; Feng F; Liu W; Liu W; You Q; Guo Q
Toxicology; 2009 May; 259(1-2):10-7. PubMed ID: 19428938
[TBL] [Abstract][Full Text] [Related]
8. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
9. Squalamine blocks tumor-associated angiogenesis and growth of human breast cancer cells with or without HER-2/neu overexpression.
Márquez-Garbán DC; Gorrín-Rivas M; Chen HW; Sterling C; Elashoff D; Hamilton N; Pietras RJ
Cancer Lett; 2019 May; 449():66-75. PubMed ID: 30771431
[TBL] [Abstract][Full Text] [Related]
10. Wogonoside inhibits tumor growth and metastasis in endometrial cancer via ER stress-Hippo signaling axis.
Chen S; Wu Z; Ke Y; Shu P; Chen C; Lin R; Shi Q
Acta Biochim Biophys Sin (Shanghai); 2019 Nov; 51(11):1096-1105. PubMed ID: 31696210
[TBL] [Abstract][Full Text] [Related]
11. LW-213 induces G2/M cell cycle arrest through AKT/GSK3β/β-catenin signaling pathway in human breast cancer cells.
Zhao L; Miao HC; Li WJ; Sun Y; Huang SL; Li ZY; Guo QL
Mol Carcinog; 2016 May; 55(5):778-92. PubMed ID: 25945460
[TBL] [Abstract][Full Text] [Related]
12. Ginkgo biloba exocarp extracts inhibits angiogenesis and its effects on Wnt/β-catenin-VEGF signaling pathway in Lewis lung cancer.
Han D; Cao C; Su Y; Wang J; Sun J; Chen H; Xu A
J Ethnopharmacol; 2016 Nov; 192():406-412. PubMed ID: 27649680
[TBL] [Abstract][Full Text] [Related]
13. Impact of ER520, a candidate of selective estrogen receptor modulators, on in vitro cell growth, migration, invasion, angiogenesis and in vivo tumor xenograft of human breast cancer cells.
Wang L; Wang Y; Du H; Jiang Y; Tang Z; Liu H; Xiang H; Xiao H
Cancer Chemother Pharmacol; 2015 Dec; 76(6):1247-57. PubMed ID: 26464351
[TBL] [Abstract][Full Text] [Related]
14. Wogonin inhibits tumor angiogenesis via degradation of HIF-1α protein.
Song X; Yao J; Wang F; Zhou M; Zhou Y; Wang H; Wei L; Zhao L; Li Z; Lu N; Guo Q
Toxicol Appl Pharmacol; 2013 Sep; 271(2):144-55. PubMed ID: 23707765
[TBL] [Abstract][Full Text] [Related]
15. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
[TBL] [Abstract][Full Text] [Related]
16. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q
Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218
[TBL] [Abstract][Full Text] [Related]
17. Wogonoside induces autophagy in MDA-MB-231 cells by regulating MAPK-mTOR pathway.
Sun Y; Zou M; Hu C; Qin Y; Song X; Lu N; Guo Q
Food Chem Toxicol; 2013 Jan; 51():53-60. PubMed ID: 23000445
[TBL] [Abstract][Full Text] [Related]
18. Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway.
Wei LH; Lin JM; Chu JF; Chen HW; Li QY; Peng J
Chin J Integr Med; 2017 Nov; 23(11):858-863. PubMed ID: 29080197
[TBL] [Abstract][Full Text] [Related]
19. Kallistatin, a novel anti-angiogenesis agent, inhibits angiogenesis via inhibition of the NF-κB signaling pathway.
Huang KF; Huang XP; Xiao GQ; Yang HY; Lin JS; Diao Y
Biomed Pharmacother; 2014 May; 68(4):455-61. PubMed ID: 24721321
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.
Pramanik KC; Fofaria NM; Gupta P; Ranjan A; Kim SH; Srivastava SK
Oncotarget; 2015 May; 6(13):11561-74. PubMed ID: 25869100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
